A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness
Recruiting
N/A
Interventional Study
Chronic Dizziness
Persistent Postural Perceptual Dizziness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous vagus nerve stimulation (aTVNS).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-75, Persistent Postural-Perceptual Dizziness (PPPD) diagnosis per International Classification of Vestibular Disorders (ICVD).
* Persistent dizziness ≥3 months and at least 1 dizziness exacerbation/day during 2-week run-in.
* On stable medications/therapy for ≥4 weeks p…
Contacts